BioCentury
ARTICLE | Clinical News

AlzheimAlert urine test regulatory update

November 15, 2004 8:00 AM UTC

NYMX received CE mark approval for its AlzheimAlert test. The test is a non-invasive urine test to measure the level of neural thread protein to diagnose Alzheimer's disease (AD). ...